Related Experiment Video
Updated: Jul 26, 2026

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant
1Division of Molecular Pharmacology, Departments of Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60607, USA.
Abstract:
DNA topoisomerase (topo) IIalpha gene expression or activity is altered in tumor cells selected for resistance to inhibitors of topoII. To better understand the mechanisms by which topoIIalpha expression levels are modulated, we examined topoIIalpha transcriptional regulation in ICRF-187-sensitive and ICRF-187-resistant human leukemic cell lines that express an increased amount of topoIIalpha protein and mRNA. Transient transfections of luciferase reporter plasmids containing either the full-length human topoIIalpha promoter or fragments of it revealed that topoIIalpha transcriptional activity was significantly increased in the drug-resistant CEM/ICRF-8 cells, compared with CEM cells. Specifically, the transcriptional activity of the full-length topoIIalpha promoter (nucleotides -557 to +90) was doubled in CEM/ICRF-8 compared with CEM cells. Serial deletion of the topoIIalpha promoter permitted localization of the region responsible for its up-regulation in the drug-resistant cells between nucleotides -557 and -162, which includes the last three inverted CCAAT elements (ICE) 3 to 5. Note that construction of a point mutation in ICE3 resulted in a significant increase in transcriptional activity of the topoIIalpha promoter in the drug-sensitive CEM cells. In addition, by electrophoretic mobility shift assay, ICE3 was recognized by a protein complex containing NF-YB that was present at reduced levels in the topoIIalpha-overexpressing CEM/ICRF-8 extracts, suggesting that ICE3 plays a negative regulatory role in human topoIIalpha gene expression. This is the first study to show that topoIIalpha transcriptional up-regulation in ICRF-187-resistant cells is mediated in part by altered regulation of the third inverted CCAAT box in the topoIIalpha promoter.
Insights
Drug resistance in leukemia involves altered DNA topoisomerase IIalpha (topoIIalpha) gene expression. This study reveals that a specific promoter region, ICE3, negatively regulates topoIIalpha, and its reduced function contributes to drug resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Tumor cells resistant to topoisomerase II (topoII) inhibitors often exhibit altered topoIIalpha gene expression.
- Understanding topoIIalpha transcriptional regulation is crucial for deciphering drug resistance mechanisms.
Purpose of the Study:
- To investigate the transcriptional regulation of the human DNA topoisomerase IIalpha (topoIIalpha) gene in drug-resistant leukemia cells.
- To identify specific promoter elements responsible for increased topoIIalpha expression in cells resistant to topoII inhibitors.
Main Methods:
- Transient transfection assays using luciferase reporter plasmids with human topoIIalpha promoter constructs.
- Analysis of promoter activity in drug-sensitive (CEM) and drug-resistant (CEM/ICRF-8) human leukemic cell lines.
- Electrophoretic mobility shift assays (EMSA) to study protein-DNA interactions within the topoIIalpha promoter.
Main Results:
- TopoIIalpha transcriptional activity was significantly increased (doubled) in drug-resistant CEM/ICRF-8 cells compared to sensitive CEM cells.
- A key regulatory region responsible for this up-regulation was localized between nucleotides -557 and -162 of the topoIIalpha promoter, encompassing inverted CCAAT elements (ICE) 3 to 5.
- A point mutation in ICE3 significantly increased promoter activity in drug-sensitive cells, and EMSA indicated reduced binding of an NF-YB containing complex to ICE3 in resistant cells, suggesting negative regulation by ICE3.
Conclusions:
- Transcriptional up-regulation of topoIIalpha in ICRF-187-resistant cells is partly mediated by altered regulation of the third inverted CCAAT box (ICE3) in the topoIIalpha promoter.
- ICE3 appears to function as a negative regulatory element in human topoIIalpha gene expression, and its diminished regulatory capacity contributes to increased topoIIalpha levels in resistant cells.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Cell Specific Gene Expression
Cis-regulatory Sequences
Master Transcription Regulators
General Transcription Factors

